Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Int J Mol Sci. 2024 Apr 24;25(9):4620. doi: 10.3390/ijms25094620.
Breast cancer (BC) is a global health risk for women and has a high prevalence rate. The drug resistance, recurrence, and metastasis of BC affect patient prognosis, thus posing a challenge to scientists. Exosomes are extracellular vesicles (EVs) that originate from various cells; they have a double-layered lipid membrane structure and contain rich biological information. They mediate intercellular communication and have pivotal roles in tumor development, progression, and metastasis and drug resistance. Exosomes are important cell communication mediators in the tumor microenvironment (TME). Exosomes are utilized as diagnostic and prognostic biomarkers for estimating the treatment efficacy of BC and have the potential to function as tools to enable the targeted delivery of antitumor drugs. This review introduces recent progress in research on how exosomes influence tumor development and the TME. We also present the research progress on the application of exosomes as prognostic and diagnostic biomarkers and drug delivery tools.
乳腺癌(BC)是全球女性的健康威胁,具有较高的患病率。BC 的耐药性、复发和转移影响患者的预后,因此对科学家构成了挑战。外泌体是源自各种细胞的细胞外囊泡(EVs);它们具有双层脂质膜结构,并且包含丰富的生物信息。它们介导细胞间通讯,在肿瘤发生、发展、转移和耐药性方面发挥关键作用。外泌体是肿瘤微环境(TME)中重要的细胞通讯介质。外泌体可用作评估 BC 治疗效果的诊断和预后生物标志物,并且有可能作为靶向递送抗肿瘤药物的工具。这篇综述介绍了外泌体如何影响肿瘤发展和 TME 的最新研究进展。我们还介绍了外泌体作为预后和诊断生物标志物以及药物递送工具的应用研究进展。